` NZYM B (Novozymes A/S) vs OMX Copenhagen 25 Comparison - Alpha Spread

NZYM B
vs
OMX Copenhagen 25

Over the past 12 months, NZYM B has underperformed OMX Copenhagen 25, delivering a return of 0% compared to the OMX Copenhagen 25's 16% drop.

Stocks Performance
NZYM B vs OMX Copenhagen 25

Loading

Performance Gap
NZYM B vs OMX Copenhagen 25

Loading
NZYM B
OMX Copenhagen 25
Difference

Performance By Year
NZYM B vs OMX Copenhagen 25

Loading
NZYM B
OMX Copenhagen 25
Add Stock

Competitors Performance
Novozymes A/S vs Peers

OMX Copenhagen 25
NZYM B
SHW
ECL
4063
GIVN
Add Stock

Novozymes A/S
Glance View

Market Cap
165.6B DKK
Industry
Chemicals

Novozymes A/S, a beacon of innovation in biotechnology, operates at the intricate intersection of science and sustainability. Born from the storied roots of Novo Nordisk in 2000, this Danish company has carved out a niche in the enzyme and microbial sector. Novozymes’ core competency lies in its ability to harness the power of natural organisms, using them to drive forward industrial solutions that are not only efficient but also eco-friendly. The company’s extensive portfolio of enzymes transforms processes across a diverse array of industries, including agriculture, food and beverages, household care, and bioenergy. By engineering microorganisms to optimize yield and reduce waste, Novozymes provides solutions that both enhance product performance and support environmental goals. Revenue generation for Novozymes predominantly stems from its ability to innovate and provide proprietary solutions that businesses around the world rely on to gain a competitive edge. While enzymes in detergents simplify stain removal and enable energy-efficient washing at lower temperatures, in agriculture, Novozymes' biological solutions enhance crop yield by fostering nutrient absorption and pest resilience. This vast spectrum of applications showcases the company's deep integration into its clients' production processes, creating a stable demand. Novozymes capitalizes on its research and development prowess, ensuring a continuous flow of advanced, tailor-made bio-solutions, thereby securing long-term partnerships and a sustainable revenue stream from its global market presence.

NZYM B Intrinsic Value
115.83 DKK
Overvaluation 71%
Intrinsic Value
Price
Back to Top